Alphatec Holdings, Inc. reported a 39% increase in total revenue to $117 million for the second quarter of 2023. Surgical revenue grew by 41% to $102 million, and EOS revenue increased by 24% to $15 million. The company also delivered positive adjusted EBITDA of over $1 million.
Total revenue grew 39% to $117 million.
Surgical revenue grew 41% to $102 million.
EOS revenue grew 24% to $15 million.
Adjusted EBITDA was positive at over $1 million.
The Company now expects total revenue to grow 32% to $462 million for the fiscal year ended December 31, 2023. This includes surgical revenue growth of approximately 33% and $58 million of EOS revenue. The Company also now expects non-GAAP adjusted EBITDA of approximately $2 million for the full year 2023.
Analyze how earnings announcements historically affect stock price performance